CY1123658T1 - Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης - Google Patents

Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης

Info

Publication number
CY1123658T1
CY1123658T1 CY20201101168T CY201101168T CY1123658T1 CY 1123658 T1 CY1123658 T1 CY 1123658T1 CY 20201101168 T CY20201101168 T CY 20201101168T CY 201101168 T CY201101168 T CY 201101168T CY 1123658 T1 CY1123658 T1 CY 1123658T1
Authority
CY
Cyprus
Prior art keywords
quinolone
quinolone compounds
synthesis
relates
making
Prior art date
Application number
CY20201101168T
Other languages
Greek (el)
English (en)
Inventor
Roger Hanselmann
Maxwell M REEVE
Graham Johnson
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of CY1123658T1 publication Critical patent/CY1123658T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
CY20201101168T 2008-09-24 2020-12-09 Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης CY1123658T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24
EP09816565.7A EP2346855B1 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds
PCT/US2009/005276 WO2010036329A2 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds

Publications (1)

Publication Number Publication Date
CY1123658T1 true CY1123658T1 (el) 2021-05-05

Family

ID=42060333

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201101168T CY1123658T1 (el) 2008-09-24 2020-12-09 Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης

Country Status (27)

Country Link
US (3) USRE46617E1 (ko)
EP (3) EP3214083B1 (ko)
JP (2) JP6013734B2 (ko)
KR (3) KR20110091504A (ko)
CN (2) CN102164912B (ko)
AU (1) AU2009297085B2 (ko)
BR (1) BRPI0919241B8 (ko)
CA (1) CA2738236C (ko)
CY (1) CY1123658T1 (ko)
DK (2) DK2346855T3 (ko)
ES (3) ES2629466T3 (ko)
FI (1) FI3766876T3 (ko)
HK (2) HK1214243A1 (ko)
HR (1) HRP20201879T1 (ko)
HU (2) HUE052219T2 (ko)
IL (1) IL211845A (ko)
LT (3) LT3766876T (ko)
MX (2) MX2011003122A (ko)
NL (1) NL301091I2 (ko)
NO (1) NO2021006I1 (ko)
PL (2) PL3766876T3 (ko)
PT (1) PT3214083T (ko)
RS (1) RS61194B1 (ko)
RU (1) RU2546667C2 (ko)
SG (1) SG10201605492YA (ko)
SI (1) SI3214083T1 (ko)
WO (1) WO2010036329A2 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
AU2009297085B2 (en) 2008-09-24 2015-07-09 Melinta Subsidiary Corp. Process for making quinolone compounds
WO2014152317A2 (en) * 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating gonorrhea infections using quinolone antibiotics
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
JP6813665B2 (ja) 2017-03-31 2021-01-13 富士フイルム株式会社 4−ピリドン化合物またはその塩、それを含む医薬組成物および剤
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2171252C2 (ru) 1995-09-22 2001-07-27 Вакунага Фармасьютикал КО., Лтд. Аминосоединение для получения новых производных пиридонкарбоновой кислоты или их солей
CZ302033B6 (cs) * 1999-07-01 2010-09-08 Wakunaga Pharmaceutical Co., Ltd. Derivát chinolinkarboxylové kyseliny a jeho soli, farmaceutický prostredek je obsahující, jejich použití
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
WO2006015194A2 (en) * 2004-07-30 2006-02-09 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
SI3056492T1 (sl) 2004-10-08 2022-03-31 Abbvie Inc. Sol meglumina in njene kristalinične oblike zdravila (delafloksacin)
MX2007012642A (es) 2005-04-11 2008-01-11 Abbott Lab Composiciones farmaceuticas que tienen perfiles mejorados de disolucion para farmacos poco solubles.
AU2009297085B2 (en) 2008-09-24 2015-07-09 Melinta Subsidiary Corp. Process for making quinolone compounds

Also Published As

Publication number Publication date
US20120041208A1 (en) 2012-02-16
SG10201605492YA (en) 2016-09-29
HUS2100004I1 (hu) 2021-03-01
FI3766876T3 (fi) 2023-12-05
US8871938B2 (en) 2014-10-28
PL3766876T3 (pl) 2024-04-02
SI3214083T1 (sl) 2021-02-26
KR101775304B1 (ko) 2017-09-05
KR20160116020A (ko) 2016-10-06
BRPI0919241B1 (pt) 2020-05-12
CN105001207A (zh) 2015-10-28
DK2346855T3 (en) 2017-07-24
WO2010036329A2 (en) 2010-04-01
LT3214083T (lt) 2021-01-25
DK3214083T3 (da) 2020-12-07
AU2009297085A1 (en) 2010-04-01
JP2012508161A (ja) 2012-04-05
NO2021006I1 (no) 2021-02-15
LTC3214083I2 (lt) 2022-06-27
EP3766876B8 (en) 2023-10-18
CN102164912B (zh) 2015-08-19
RU2011116052A (ru) 2012-10-27
CA2738236C (en) 2016-11-15
HRP20201879T1 (hr) 2021-01-22
HK1244481A1 (zh) 2018-08-10
BRPI0919241A2 (pt) 2016-06-21
HUE052219T2 (hu) 2021-04-28
AU2009297085B2 (en) 2015-07-09
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
MX2020009790A (es) 2020-10-12
BRPI0919241B8 (pt) 2021-05-25
EP2346855B1 (en) 2017-04-05
JP2015178515A (ja) 2015-10-08
EP2346855A2 (en) 2011-07-27
USRE46617E1 (en) 2017-11-28
ES2966093T3 (es) 2024-04-18
PT3214083T (pt) 2020-12-04
ES2826273T3 (es) 2021-05-17
NL301091I1 (nl) 2021-02-10
MX2011003122A (es) 2011-07-20
JP6013734B2 (ja) 2016-10-25
EP3766876A1 (en) 2021-01-20
EP3214083A1 (en) 2017-09-06
HK1214243A1 (zh) 2016-07-22
EP2346855A4 (en) 2012-07-04
CN102164912A (zh) 2011-08-24
EP3766876B1 (en) 2023-09-13
US20140171648A1 (en) 2014-06-19
IL211845A (en) 2017-03-30
CA2738236A1 (en) 2010-04-01
WO2010036329A3 (en) 2010-07-01
EP3214083B1 (en) 2020-09-16
NL301091I2 (nl) 2021-08-03
ES2629466T3 (es) 2017-08-09
IL211845A0 (en) 2011-06-30
LT3766876T (lt) 2023-12-11
LTPA2021002I1 (lt) 2021-03-10
US8497378B2 (en) 2013-07-30
BRPI0919241A8 (pt) 2017-10-17
KR20170039758A (ko) 2017-04-11
PL3214083T3 (pl) 2021-04-06
RS61194B1 (sr) 2021-01-29

Similar Documents

Publication Publication Date Title
CY1123658T1 (el) Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
EA201100666A1 (ru) Тиоамидные соединения, способ их получения и способ их применения
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
MX2013006926A (es) Compuestos y composiciones fotocromicas.
CY1113716T1 (el) Νεα μεθοδος συνθεσης της αγομελατινης
CY1112829T1 (el) Νεα μεθοδος συνθεσης για την αγομελατινη
ATE539054T1 (de) Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte
CY1113184T1 (el) Μεθοδος για την παρασκευη θεραπευτικως πολυτιμων παραγωγων τριφαινυλβουτενιου
MY150778A (en) Fused heterocyclic compound
DE602007003357D1 (de) Verfahren zur herstellung sterisch gehinderter nitroxylether
EA201070467A1 (ru) Способ модификации твердого состояния соединения и соаморфные композиции, полученные этим способом
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
DK2285765T3 (da) Fremgangsmåde til fremstilling af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre
UA110802C2 (uk) Моногідрат похідного азаадамантану
CY1114493T1 (el) Διαδικασια για την παρασκευη μιας ενωσης χρησιμης ως αναστολεα της tafia
EA200870038A1 (ru) Способ получения аминов
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
CY1114749T1 (el) Μια διεργασια για την παρασκευη ενωσεων καρβαπενεμης
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
EA201270237A1 (ru) Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения, содержащие магний
CY1111573T1 (el) Νεα μεθοδος συνθεσης της αγομελατινης
WO2009116081A3 (en) An improved process for the preparation of aprepitant
CY1111873T1 (el) Νεα μεθοδος παραλαβης της κρυσταλλικης μορφης v της αγομελατινης
EA201001406A1 (ru) СПОСОБ ПОЛУЧЕНИЯ БЕНЗОТИАЗЕПИНОВ ИЗ γ-АМИНОАЛКИЛБЕНЗОЛОВ